Shanghai Hile Bio-Technology (SHA:603718) subsidiary Shaanxi Ruisheng Biotechnology will acquire a 51% stake in seven dental clinics in Yangzhou and Changzhou, China, for 61.2 million yuan.
The transaction is expected to contribute 7 million yuan in net profit in 2026, according to a Thusrday filing with the Shanghai bourse.
The clinics will pledge the remaining 49% to Ruisheng Biotechnology to guarantee their performance and impairment compensation obligations, the filing said.